China Medical GatewayLoading your healthcare gateway…

Li He Cheng

Li He Cheng — Chief Physician — Thoracic Surgery — Shanghai Ruijin Hospital

Specialties

Comprehensive treatment primarily using minimally invasive surgery for lung cancer, esophageal cancer, cardia cancer, and mediastinal tumors; minimally invasive treatment for hyperhidrosis, pleural diseases, chest wall diseases, and others. Skilled in precise minimally invasive surgeries such as thoracoscopy and Da Vinci robotic surgery.

Education

From 2000 to 2005, studied as a clinical medical skills graduate student in tumor surgery at Fudan University Cancer Hospital, and obtained a PhD in tumor surgery from Fudan University in 2005. In 2004 and 2011, received funding from the Union for International Cancer Control and Fudan University Cancer Hospital, respectively, to study at Vanderbilt University Cancer Center, MD Anderson Cancer Center of the University of Texas, and Duke University Medical Center, focusing on minimally invasive surgery for lung cancer and esophageal cancer (thoracoscopic surgery and robotic surgery) and comprehensive treatment of pleural mesothelioma.

Professional Experience

Chief physician, doctoral supervisor, director of the Department of Thoracic Surgery. Since 1996, engaged in clinical diagnosis and treatment of thoracic surgical tumors. In December 2014, introduced by Ruijin Hospital affiliated to Jiaotong University School of Medicine to lead general thoracic surgery work. He has presided over 2 National Natural Science Foundation projects and 2 Shanghai Science and Technology Commission projects, included in the Shanghai Science and Technology Rising Star and Shanghai Science and Technology Rising Star Tracking Talent Training Program, mainly conducting clinical basic research on lung cancer, esophageal cancer, and mesothelioma. He has received honors from the Shanghai Science and Technology Rising Star / Rising Star Tracking Talent Program, the Third Prize of the Chinese Anti-Cancer Association Science and Technology Progress Award (for surgical treatment of esophageal cancer), the 17th Meiji Life Science Award, and has participated in the compilation of 5 oncology monographs.

Professional Roles

Chair of the Youth Committee of the Thoracic Tumor Professional Committee of the Shanghai Anti-Cancer Association; member of the International Association for Lung Cancer Research, American Society of Clinical Oncology, American Association for Cancer Research, Union for International Cancer Control, Chinese Society of Clinical Oncology, International Chinese Society of Thoracic Surgeons, and Shanghai Invention Association. Serves as a reviewer for BMC CANCER, Anti-cancer Drug, BMC COMPLEMENT ALTERN M, BREAST CANCER RES TREAT, English edition of The Chinese Medical Journal, Tumor, and China Cancer, and as an evaluation expert for the National Natural Science Foundation and Shanghai Science and Technology Commission projects.

Return to Home